NFSG Corp Purchases 25,700 Shares of Axon Enterprise, Inc $AXON

NFSG Corp raised its position in Axon Enterprise, Inc (NASDAQ:AXON) by 4,904.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,224 shares of the biotechnology company’s stock after buying an additional 25,700 shares during the period. Axon Enterprise comprises 1.1% of NFSG Corp’s investment portfolio, making the stock its 22nd biggest position. NFSG Corp’s holdings in Axon Enterprise were worth $11,080,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. V Square Quantitative Management LLC raised its holdings in Axon Enterprise by 7.3% in the 3rd quarter. V Square Quantitative Management LLC now owns 2,055 shares of the biotechnology company’s stock worth $868,000 after purchasing an additional 140 shares during the period. Assenagon Asset Management S.A. boosted its position in Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after purchasing an additional 4,183,302 shares in the last quarter. RDA Financial Network boosted its position in Axon Enterprise by 807.1% during the third quarter. RDA Financial Network now owns 32,339 shares of the biotechnology company’s stock worth $13,664,000 after purchasing an additional 28,774 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in Axon Enterprise by 7,382.5% in the third quarter. State of Alaska Department of Revenue now owns 590,965 shares of the biotechnology company’s stock valued at $249,695,000 after purchasing an additional 583,067 shares during the period. Finally, Formuepleje A S acquired a new stake in Axon Enterprise in the third quarter valued at approximately $284,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 2.1%

AXON stock opened at $417.19 on Friday. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $764.02. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm has a 50-day simple moving average of $505.21 and a 200-day simple moving average of $475.02. The stock has a market capitalization of $33.89 billion, a P/E ratio of 173.11, a P/E/G ratio of 7.69 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same period last year, the company posted $2.12 EPS. Axon Enterprise’s quarterly revenue was up 35.3% compared to the same quarter last year. Equities analysts forecast that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of a number of recent analyst reports. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Morgan Stanley upped their target price on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Barclays increased their target price on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Finally, Argus lifted their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $718.47.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the transaction, the president owned 296,974 shares in the company, valued at $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares in the company, valued at $27,032,038.80. This represents a 1.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 47,397 shares of company stock valued at $26,722,984 in the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.